VYNE Therapeutics
VYNE
VYNE
54 hedge funds and large institutions have $64.3M invested in VYNE Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 55 → 54 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.92M | |
| 2 | +$450K | |
| 3 | +$215K | |
| 4 |
Renaissance Technologies
New York
|
+$125K |
| 5 |
State Street
Boston,
Massachusetts
|
+$98.2K |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$808K | |
| 3 | -$633K | |
| 4 |
DM
Deerfield Management
New York
|
-$446K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$276K |